Aon’s tech startup approach is redefining life insurance September 18, 2025 When Michelle Lister joined Aon to startup a life consulting practice, she didn’t expect to find a high-performing GPU based life actuarial software ready to use for her projects. But that’s exactly what happened. “The draw was the excitement of having this startup of a business within a global corporate,” says Lister, now UK/EMEA head [...]
Mounjaro sales help almost double Ely Lilly’s UK turnover September 18, 2025 The sale of weight loss drug Mounjaro has boosted the UK turnover of pharmaceuticals giant Eli Lilly by 90 per cent during its latest financial year, it has been revealed. The division of the US group has posted a turnover of £889m for 2024, according to new accounts filed with Companies House. The new total [...]
The “Living Bridge”: Cultivating a new golden era in UK-India relations September 18, 2025 The India Business Group (IBG), an independent strategic advisory company, was established in 2014 by Amarjit Singh to foster the special relationship between India and the UK. The founder and CEO of the India Business Group is a commercial solicitor by background and set up the organisation after observing a palpable interest from UK small [...]
Ben Proud’s Enhanced Games switch puts pressure IOC to use its $5bn September 18, 2025 Rather than wondering why Ben Proud would sign up for the Enhanced Games, it is better to ask why he wouldn’t. The British swimmer’s commitment to the competition with an “anything goes” attitude to performance-enhancing drugs is a wake-up call for the Olympic movement. Money, as ever, lies at the heart of the matter. Proud [...]
Why is the pharmaceutical industry turning its back on the UK? September 18, 2025 Since coming into power last year, Rachel Reeves and Keir Starmer have consistently stressed the importance of the life science sector to the UK economy, viewing it as critical for growth. In its aim to boost the industry’s standing, Labour pledged to make the UK an attractive place for investment and innovation, and to increase [...]
City of London unveils £600m Justice Hub at Salisbury Square September 18, 2025 The City of London Corporation is topping out the new flagship building, dubbed London’s new ‘Justice Quarter’, which features 18 courtrooms at Salisbury Square. The City’s £600m investment, which will serve as the new headquarters for the City of London Police, aims to enhance capacity in the criminal justice system, resulting in faster outcomes for [...]
Surinder Arora: Heathrow could be the next Thames Water September 17, 2025 Surinder Arora is the man bidding to break a decades-old monopoly by winning the right to build Heathrow’s third runway. With the government’s first remarks on proposals expected this month, he sits down with Ali Lyon to discuss the merits of his proposal, the reasons behind it, and why he thinks that – without urgent [...]
Why public markets are a public good September 17, 2025 Far from being irrelevant, UK public equity markets are a vital public good essential for tax revenue, corporate transparency, and economic growth, which requires urgent tax reforms to encourage companies to list and remain in the UK, says Charles Hall There is a school of thought that thinks public equity markets are relatively unimportant and [...]
Fraud prevention firm SEON raises $80m amid growing compliance demands September 16, 2025 SEON, an AI-driven fraud prevention and compliance platform, has closed an $80m (£58.7m) Series C funding round led by Sixth Street Growth, bringing total investment to $187m. The company, based in Budapest and Austin, analyses tens of millions of customer interactions daily for clients including Revolut, Plaid, Spotify, Afterpay, and Entain. Its platform, delivered via [...]
Big pharma’s devastating retreat from the UK September 16, 2025 Merck and AstraZeneca’s withdrawal from UK investment is a warning signal to Rachel Reeves – but is she listening? Asks Oliver Dean Both AstraZeneca and Merck’s decision to abandon their respective UK expansions is more than a corporate setback. It is a catastrophic loss of jobs, investment and future innovation and the public are now [...]